Literature DB >> 4160875

Cyclophosphamide treatment of kidney disease in (NZB x NZW) F1 mice.

P J Russell, J D Hicks, F M Burnet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4160875

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Nephrotic syndrome of childhood: malaria therapy reconsidered.

Authors:  T M Barratt
Journal:  Arch Dis Child       Date:  1979-11       Impact factor: 3.791

2.  Cyclophosphamide inhibition of insulin antibody production, insulin resistance and experimental immunodiabetes.

Authors:  L Korcáková; M Titlbach; K Nouza
Journal:  Acta Diabetol Lat       Date:  1972 Nov-Dec

Review 3.  The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease.

Authors:  Brian P O'Connor; Michael W Gleeson; Randolph J Noelle; Loren D Erickson
Journal:  Immunol Rev       Date:  2003-08       Impact factor: 12.988

4.  Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation.

Authors:  S Slavin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

5.  Aleutian disease of mink. Prevention of lesions by immunosuppression.

Authors:  A Cheema; J B Henson; J R Gorham
Journal:  Am J Pathol       Date:  1972-03       Impact factor: 4.307

6.  CD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanisms.

Authors:  Èlia Ripoll; Ana Merino; Immaculada Herrero-Fresneda; Josep M Aran; Montse Goma; Nuria Bolaños; Laura de Ramon; Oriol Bestard; Josep M Cruzado; Josep M Grinyó; Juan Torras
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

7.  Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus.

Authors:  Victoria L Wolf; Erin B Taylor; Michael J Ryan
Journal:  Physiol Rep       Date:  2019-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.